Literature DB >> 13678762

A case of valproate-associated hepatotoxicity treated with L-carnitine.

Auxiliadora Romero-Falcón1, Eva de la Santa-Belda, Rosa García-Contreras, José M. Varela.   

Abstract

Valproate is a major broad-spectrum anti-epileptic drug that is effective against many different types of epileptic seizures and that is usually well tolerated. Nevertheless, serious side effects can occur, including hepatotoxicity. This side effect is rare but often fatal, and it has been hypothesized that long-term valproate therapy may induce a carnitine deficiency and cause non-specific symptoms of hepatotoxicity and hyperammonemia. These factors suggest that L-carnitine supplementation may play a role in preventing hepatotoxicity. We report a case of valproate-induced acute liver injury with a favorable evolution after L-carnitine therapy.

Entities:  

Year:  2003        PMID: 13678762     DOI: 10.1016/s0953-6205(03)00104-3

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  4 in total

Review 1.  Dispensability of Annual Laboratory Follow-Up After More than 2 Years of Valproic Acid Use: A Systematic Review.

Authors:  Rosanne W Meijboom; Koen P Grootens
Journal:  CNS Drugs       Date:  2017-11       Impact factor: 5.749

Review 2.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

Review 3.  Drugs and pharmaceuticals: management of intoxication and antidotes.

Authors:  Silas W Smith
Journal:  EXS       Date:  2010

4.  Posterior reversible encephalopathy syndrome in a survivor of valproate-induced acute liver failure: a case report.

Authors:  Sachith Mettananda; Asvini D Fernando; Nimasari Ginige
Journal:  J Med Case Rep       Date:  2013-05-31
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.